Conservest Capital Advisors Inc. Sells 2,910 Shares of SPDR S&P Biotech ETF $XBI

Conservest Capital Advisors Inc. lessened its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.2% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 28,664 shares of the exchange traded fund’s stock after selling 2,910 shares during the quarter. Conservest Capital Advisors Inc. owned approximately 0.05% of SPDR S&P Biotech ETF worth $2,377,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of XBI. JPMorgan Chase & Co. grew its stake in shares of SPDR S&P Biotech ETF by 625.1% in the first quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock worth $840,983,000 after purchasing an additional 12,344,558 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in shares of SPDR S&P Biotech ETF by 33.0% in the first quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock worth $1,096,866,000 after purchasing an additional 3,353,029 shares during the last quarter. Simplex Trading LLC grew its stake in shares of SPDR S&P Biotech ETF by 116.1% in the first quarter. Simplex Trading LLC now owns 241,039 shares of the exchange traded fund’s stock worth $19,548,000 after purchasing an additional 1,741,445 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. bought a new stake in shares of SPDR S&P Biotech ETF in the first quarter worth $85,155,000. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new stake in SPDR S&P Biotech ETF during the first quarter valued at $48,660,000.

SPDR S&P Biotech ETF Trading Up 0.8%

Shares of NYSEARCA XBI opened at $108.39 on Friday. The firm’s 50-day moving average price is $98.08 and its 200-day moving average price is $87.88. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $110.96. The firm has a market capitalization of $6.65 billion, a P/E ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.